In mice, activation of STAT3 and expression of SOCS3 is characteristic for the development of IBD and colitis, with SOCS3 acting as a regulatory mechanism to limit pathogenesis, which is primarily driven through macrophages (225). The gene discussed is STAT3; the disease is colitis.